Template:PDB Gallery/1432

• 1a9u: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580

  1a9u: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580

• 1bl6: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995

  1bl6: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995

• 1bl7: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025

  1bl7: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025

• 1bmk: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655

  1bmk: THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655

• 1di9: THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE

  1di9: THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE

• 1ian: HUMAN P38 MAP KINASE INHIBITOR COMPLEX

  1ian: HUMAN P38 MAP KINASE INHIBITOR COMPLEX

• 1kv1: p38 MAP Kinase in Complex with Inhibitor 1

  1kv1: p38 MAP Kinase in Complex with Inhibitor 1

• 1kv2: Human p38 MAP Kinase in Complex with BIRB 796

  1kv2: Human p38 MAP Kinase in Complex with BIRB 796

• 1lew: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A

  1lew: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A

• 1lez: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B

  1lez: CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B

• 1m7q: Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor

  1m7q: Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor

• 1ouk: The structure of p38 alpha in complex with a pyridinylimidazole inhibitor

  1ouk: The structure of p38 alpha in complex with a pyridinylimidazole inhibitor

• 1ouy: The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor

  1ouy: The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor

• 1ove: The structure of p38 alpha in complex with a dihydroquinolinone

  1ove: The structure of p38 alpha in complex with a dihydroquinolinone

• 1oz1: P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR

  1oz1: P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR

• 1p38: THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTOMS RESOLUTION

  1p38: THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTOMS RESOLUTION

• 1r39: THE STRUCTURE OF P38ALPHA

  1r39: THE STRUCTURE OF P38ALPHA

• 1r3c: THE STRUCTURE OF P38ALPHA C162S MUTANT

  1r3c: THE STRUCTURE OF P38ALPHA C162S MUTANT

• 1w7h: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

  1w7h: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

• 1w82: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

  1w82: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

• 1w83: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

  1w83: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

• 1w84: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

  1w84: P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR

• 1wbn: FRAGMENT BASED P38 INHIBITORS

  1wbn: FRAGMENT BASED P38 INHIBITORS

• 1wbo: FRAGMENT BASED P38 INHIBITORS

  1wbo: FRAGMENT BASED P38 INHIBITORS

• 1wbs: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

  1wbs: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

• 1wbt: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

  1wbt: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

• 1wbv: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

  1wbv: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

• 1wbw: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

  1wbw: IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.

• 1wfc: STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN

  1wfc: STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN

• 1yqj: Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor

  1yqj: Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor

• 1yw2: Mutated Mus Musculus P38 Kinase (mP38)

  1yw2: Mutated Mus Musculus P38 Kinase (mP38)

• 1ywr: Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor

  1ywr: Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor

• 1zyj: Human P38 MAP Kinase in Complex with Inhibitor 1a

  1zyj: Human P38 MAP Kinase in Complex with Inhibitor 1a

• 1zz2: Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes

  1zz2: Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes

• 1zzl: Crystal structure of P38 with triazolopyridine

  1zzl: Crystal structure of P38 with triazolopyridine

• 2baj: p38alpha bound to pyrazolourea

  2baj: p38alpha bound to pyrazolourea

• 2bak: p38alpha MAP kinase bound to MPAQ

  2bak: p38alpha MAP kinase bound to MPAQ

• 2bal: p38alpha MAP kinase bound to pyrazoloamine

  2bal: p38alpha MAP kinase bound to pyrazoloamine

• 2baq: p38alpha bound to Ro3201195

  2baq: p38alpha bound to Ro3201195

• 2ewa: Dual binding mode of pyridinylimidazole to MAP kinase p38

  2ewa: Dual binding mode of pyridinylimidazole to MAP kinase p38

• 2fsl: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A

  2fsl: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A

• 2fsm: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B

  2fsm: mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B

• 2fso: mitogen activated protein kinase p38alpha (D176A) activating mutant

  2fso: mitogen activated protein kinase p38alpha (D176A) activating mutant

• 2fst: mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant

  2fst: mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant

• 2gfs: P38 Kinase Crystal Structure in complex with RO3201195

  2gfs: P38 Kinase Crystal Structure in complex with RO3201195

• 2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743

  2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743

• 2ghm: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449

  2ghm: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449

• 2gtm: Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579

  2gtm: Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579

• 2gtn: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717

  2gtn: Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717

• 2i0h: The structure of p38alpha in complex with an arylpyridazinone

  2i0h: The structure of p38alpha in complex with an arylpyridazinone

• 2okr: Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer

  2okr: Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer

• 2onl: Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer

  2onl: Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer

• 2oza: Structure of p38alpha complex

  2oza: Structure of p38alpha complex